Phase 2 Chronic Liver Failure Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
F573 for Injection for the Treatment of Liver Injury/Failure
Acute-On-Chronic Liver FailureAcute Liver Failure
Beijing Continent Pharmaceutical Co, Ltd.97 enrolled10 locationsNCT05689645
Recruiting
Phase 2
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Liver CirrhosisDecompensated Cirrhosis of LiverAcute on Chronic Liver Failure (ACLF)
European Foundation for Study of Chronic Liver Failure90 enrolled9 locationsNCT05895136
Recruiting
Phase 1Phase 2
Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients
Acute-On-Chronic Liver Failure
Sun Yat-sen University90 enrolled1 locationNCT06740149
Recruiting
Phase 1Phase 2
Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Acute-On-Chronic Liver Failure
Beijing 302 Hospital150 enrolled1 locationNCT05985863